辉瑞(PFE)和BioNTech在英国赢得mRNA疫苗专利诉讼

金吾财讯
09 Oct 2024

金吾财讯 | 据媒体,辉瑞(PFE)及其德国合作伙伴BioNTech于周二在伦敦高等法院赢得了使竞争对手CureVac的两项专利无效的诉讼。辉瑞和BioNTech于2022年9月就mRNA技术专利提起诉讼,该技术是辉瑞和BioNTech的COVID-19疫苗的基础。值得注意的是,周二的裁决仅针对辉瑞、BioNTech和CureVac发起的“全球法律战”在伦敦的诉讼,三方还涉及在美国和德国的诉讼。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10